Gennex Laboratories consolidated net profit declines 48.44% in the March 2025 quarter

Sales rise 20.39% to Rs 40.33 crore

Net profit of Gennex Laboratories declined 48.44% to Rs 2.32 crore in the quarter ended March 2025 as against Rs 4.50 crore during the previous quarter ended March 2024. Sales rose 20.39% to Rs 40.33 crore in the quarter ended March 2025 as against Rs 33.50 crore during the previous quarter ended March 2024.

For the full year,net profit rose 30.84% to Rs 16.12 crore in the year ended March 2025 as against Rs 12.32 crore during the previous year ended March 2024. Sales rose 59.04% to Rs 137.90 crore in the year ended March 2025 as against Rs 86.71 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	40.33	33.50	20	137.90	86.71	59
OPM %	14.51	18.72	-	19.69	25.30	-
PBDT	4.65	5.53	-16	23.54	18.86	25
PBT	4.10	5.30	-23	21.55	16.49	31
NP	2.32	4.50	-48	16.12	12.32	31

Powered by Capital Market - Live News